Ocular Surface Review

Making the Grade

Studies show promising results for CyclASol, a new medication to treat DED that could be approved next year.
11/15/2022

Revisit a Steroid Alternative

Acthar Gel, an injectable therapy that activates melanocortin pathways, may be a saving grace for some of your patients.
09/15/2022

Power Trio

Three promising new therapeutics look to dramatically change dry eye disease management.
07/15/2022

Night Moves

Inadequate lid closure, caused by nocturnal evaporative stress, may be the reason for your patient’s dry eye.
06/15/2022

A Sticky Subject

Mucin dysfunction in dry eye is more common than you think.
03/15/2022

Neurological DED Management in Action

Promising new treatments consider a different route to alleviation of symptoms.
12/15/2021

A Disease for All Seasons

Don’t be fooled by its name: vernal keratoconjunctivitis can cause problems year-round. Heed these pearls to aid care.
10/15/2021

Fighting Fungal Keratitis

Though rare, this virulent infection can be mistaken for more benign varieties, with potentially devastating results.
08/15/2021

Five Easy Pieces

Follow these steps to increase your dry eye diagnostic accuracy.
06/15/2021

End of the Line for EBMD

More than just an annoyance, this condition can alter refractive status in ways that complicate outcomes for surgical patients
04/15/2021

Upcoming Events

December 9-10, 2022

West Coast Optometric Glaucoma Symposium
Location: Hilton La Jolla Torrey Pines
Program Co-chairs: Murray Fingeret, OD, and Robert N. Weinreb, MD
Up to 12 LIVE COPE Credits (approval pending)

Register here

December 10-11, 2022

Retina Update 2022
Location: Hilton La Jolla Torrey Pines
Program Co-chairs: Mohammad Rafieetary, OD, and Steven Ferrucci, OD
Up to 11 LIVE COPE Credits (approval pending)

Register here